Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 184, Issue 6, 2001, Pages 1267-1272

  Tidwell, S Craig ^a   Ho, Hong Nerng ^c   Chiu, Wen Hsin ^c   Torry, Ronald J ^b   Torry, Donald S ^a,d  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^b DRAKE UNIVERSITY   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Placenta growth factor; Preeclampsia; Pregnancy; Trophoblast

Indexed keywords

GROWTH FACTOR; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GESTATIONAL AGE; HUMAN; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

EID: 0035339698     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.113129     Document Type: Article

References (26)

1. Myatt L, Miodovnik M. Prediction of preeclampsia. Semin Perinatol 1999;23:45-57.
2. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. BJOG 1986;93:1049-59.
3. Esterman A, Greco MA, Mitani Y, Finlay TH, Ismail-Beigi F, Dancis J. The effect of hypoxia on human trophoblast in culture: Morphology, glucose transport and metabolism. Placenta 1997;18:2-3.
4. Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996;97:540-50.
5. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 1997;277:1669-72.
6. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype: One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997;99:2152-64.
7. Jones CJ, Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta 1980;1:61-76.
8. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:5-15.
9. Torry DS, Ahn H, Barnes EL, Torry RJ. Placenta growth factor: Potential role in pregnancy. Am J Reprod Immunol 1999;41:79-85.
10. Ziche M, Maglione D, Ribatti D, Morbidelli L, Lago CT, Battisti M, et al. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest 1997;76:517-31.
11. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 1991;88:9267-71.
12. Clark DE, Smith SK, Licence D, Evans AL, Charnock-Jones DS. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol 1998;159:459-67.
13. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997;18:657-65.
14. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998;179:1539-44.
15. Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. BJOG 1999;106:1019-22.
16. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Washington: The College; 1996. ACOG Technical Bulletin No.: 219.
17. Clark DE, Smith SK, Sharkey AM, Charnock-Jones DS. Localization of VEGF and expression of its receptors fit and KDR in human placenta throughout pregnancy. Hum Reprod 1996;11:1090-8.
18. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
19. Athanassiades A, Lala PK. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 1998;19:465-73.
20. Desai J, Holt-Shore V, Torry RJ, Caudle MR, Torry DS. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod 1999;60:887-92.
21. Runic R, Lockwood CJ, LaChapelle L, Dipasquale B, Demopoulos RI, Kumar A, et al. Apoptosis and Fas expression in human fetal membranes. J Clin Endocrinol Metab 1998;83:660-6.
22. Chan CG, Lao TT, Cheung AN. Apoptotic and proliferative activities in first trimester placentae. Placenta 1999;20:223-7.
23. DiFederico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999;155:293-301.
24. Allaire AD, Ballenger KA, Wells SR, Mcmahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol 2000;96:271-6.
25. Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997;56:489-94.
26. Norwitz ER, Robinson JN, Repke JT. Prevention of preeclampsia: Is it possible? Clin Obstet Gynecol 1999;42:436-54.